Amy T Peters1, Andrew D Peckham2, Jonathan P Stange3, Louisa G Sylvia4, Natasha S Hansen5, Stephanie Salcedo5, Scott L Rauch6, Andrew A Nierenberg4, Darin D Dougherty4, Thilo Deckersbach7. 1. University of Illinois at Chicago, Chicago, IL, USA. 2. Unversity of California at Berkeley, Berkeley, CA, USA. 3. Temple University, Philadelphia, PA, USA. 4. Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. 5. Massachusetts General Hospital, Boston, MA, USA. 6. Harvard Medical School, Boston, MA, USA; McLean Hospital, Belmont, MA, USA. 7. Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: tdeckersbach@partners.org.
Abstract
BACKGROUND: Bipolar disorder is characterized by impairments in cognitive functioning, both during acute mood episodes and periods of euthymia, which interfere with functioning. Cognitive functioning is typically assessed using laboratory-based tests, which may not capture how cognitive dysfunction is experienced in real-life settings. Little is known about the specific illness characteristics of bipolar disorder that contribute to cognitive dysfunction in everyday life. METHODS: Participants met DSM-IV criteria for bipolar I disorder (n = 68) in a depressed or euthymic state. Everyday executive functioning was evaluated using the Behavior Rating Inventory of Executive Functioning (BRIEF) and the Frontal Systems Behavior Rating Scale (FrSBe). Participants completed clinician rated measures of mood state (Hamilton Depression Rating Scale, Young Mania Rating Scale), prior illness course and co-morbidities (Mini International Neuropsychiatric Interview), as well as self-report measures of psychotropic medication use and medical co-morbidity. RESULTS: Individuals in this study reported significant impairment in every domain of executive functioning. These deficits were associated with a multitude of illness factors, some directly impacted by mood symptoms and others shaped by illness chronicity, psychiatric comorbidity, medical co-morbidity, and medication use. DISCUSSION: Executive functioning problems observed in everyday functioning in bipolar disorder are not entirely mood-state dependent. Cognitive rehabilitation for executive dysfunction should be considered an important adjunctive treatment for many individuals with bipolar disorder.
BACKGROUND:Bipolar disorder is characterized by impairments in cognitive functioning, both during acute mood episodes and periods of euthymia, which interfere with functioning. Cognitive functioning is typically assessed using laboratory-based tests, which may not capture how cognitive dysfunction is experienced in real-life settings. Little is known about the specific illness characteristics of bipolar disorder that contribute to cognitive dysfunction in everyday life. METHODS:Participants met DSM-IV criteria for bipolar I disorder (n = 68) in a depressed or euthymic state. Everyday executive functioning was evaluated using the Behavior Rating Inventory of Executive Functioning (BRIEF) and the Frontal Systems Behavior Rating Scale (FrSBe). Participants completed clinician rated measures of mood state (Hamilton Depression Rating Scale, Young Mania Rating Scale), prior illness course and co-morbidities (Mini International Neuropsychiatric Interview), as well as self-report measures of psychotropic medication use and medical co-morbidity. RESULTS: Individuals in this study reported significant impairment in every domain of executive functioning. These deficits were associated with a multitude of illness factors, some directly impacted by mood symptoms and others shaped by illness chronicity, psychiatric comorbidity, medical co-morbidity, and medication use. DISCUSSION: Executive functioning problems observed in everyday functioning in bipolar disorder are not entirely mood-state dependent. Cognitive rehabilitation for executive dysfunction should be considered an important adjunctive treatment for many individuals with bipolar disorder.
Authors: Lucy J Robinson; Jill M Thompson; Peter Gallagher; Utpal Goswami; Allan H Young; I Nicol Ferrier; P Brian Moore Journal: J Affect Disord Date: 2006-03-06 Impact factor: 4.839
Authors: A Carlo Altamura; Matteo Porcellana; Paola M Marinaccio; Maria Ciabatti; Emanuela P Nocito; Lorenzo Magri; Cinzia Bressi Journal: Gen Hosp Psychiatry Date: 2011-02-12 Impact factor: 3.238
Authors: Adriane R Rosa; María Reinares; Erin E Michalak; C Mar Bonnin; Brisa Sole; Carolina Franco; Mercè Comes; Carla Torrent; Flávio Kapczinski; Eduard Vieta Journal: Value Health Date: 2010-12 Impact factor: 5.725
Authors: Anabel Martínez-Arán; Eduard Vieta; María Reinares; Francesc Colom; Carla Torrent; Jose Sánchez-Moreno; Antonio Benabarre; José Manuel Goikolea; Mercè Comes; Manel Salamero Journal: Am J Psychiatry Date: 2004-02 Impact factor: 18.112
Authors: Faith B Dickerson; John J Boronow; Cassie R Stallings; Andrea E Origoni; Sara Cole; Robert H Yolken Journal: Psychiatr Serv Date: 2004-01 Impact factor: 3.084
Authors: Jonathan P Stange; Jessica L Hamilton; Taylor A Burke; Evan M Kleiman; Jared K O'Garro-Moore; Nicole D Seligman; Lyn Y Abramson; Lauren B Alloy Journal: Psychiatry Res Date: 2015-01-08 Impact factor: 3.222
Authors: Elaine M Boland; Jonathan P Stange; Ashleigh Molz Adams; Denise R LaBelle; Mian-Li Ong; Jessica L Hamilton; Samantha L Connolly; Chelsea L Black; Angelo B Cedeño; Lauren B Alloy Journal: Psychiatry Res Date: 2015-10-09 Impact factor: 3.222
Authors: Ezra Wegbreit; Grace K Cushman; Alexandra B Weissman; Erin Bojanek; Kerri L Kim; Ellen Leibenluft; Daniel P Dickstein Journal: J Affect Disord Date: 2016-05-26 Impact factor: 4.839